The Discovery of GSK2251052: A First-in-Class Boron ... - Anacor

Acknowledgements
To Everyone at ANACOR especially
Discovery Biology: M.R.K. Alley, J. Fong,
W. Mao, M. Mohan, M. Meewan, F. Rock,
Pharmacology: P. Torres, H. Sexton,
Y. Freund
Computational Chemistry: Y. Zhou, D.
Sullivan
Medicinal Chemistry: T. Akama, YK
Zhang, Y. Zhang, J. Plattner
PKDM: XQ. Fan, W. Bu, L. Liu
Program Management: S. Lux, S. Baker,
K. Maples
Toxicology: S. Chanda, C. Chen, I. Heyman
Clinical: F. Heerinckx, L. Zane
All studies were conducted after review by the Institutional Animal
Care and Use Committee at GSK and in accordance with the GSK
Policy on the Care, Welfare and Treatment of Laboratory Animals
EMBL: A. Palencia, T. Crepin, S. Cusack
HPA: D. Livermore, M. Warner, S. Mushtaq
NAEJA: J. Nieman, M. Anugula, N. Babu, M. Baek
C. Diaper, C. Ha, M. Kelly, M. Keramane, X. Lu, R.
Mohammad, R. Patnam, K. Savariraj, R. Sharma,
R. Subedi, I. Sidhu, R. Singh
Curragh Chemistries Inc: J. Phillips
Chiral Technologies: L. Cole, E. Esksteen
Chirosolve: N. Vaidya
RICERCA: A. O’Leary
JMI: R. Mendes, D. Biedenbach, H. Sader
R. Jones
IHMA: S. Bouchillon, M. Hackel, D. Hoban
S. Hawser
CMAX/University South Australia:
S. Shakib, R. Milne
Penn State: Steve Benkovic
To Everyone at GSK especially
P. DeMarsh, N. Pearson, E. Dumont, P. Elefante, J. Hoover, C. Jakielaszek, C. Mininger, R. Page, N. Scangarella-
Oman, C. Singley, N. Simon, S. Rittenhouse, J. Tomayko, 48 K. Widdowson, D. Payne, J. Conde, A. Kowalski, M. Zajac 48